UNSPSC 51285905: Etisomicin

This classification denotes an antibiotic with the molecular formula C20H39N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0BZK9FE5DE, chemically known as o-3-deoxy-3-(ethylamino)-4-c-methyl-beta-l-arabinopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1->6))-2-deoxy-l-streptamine. but more generally known as etisomicin, which bears US NIH Compound Identifier 216268.

European Medicines Agency schedules Etisomicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07311MIG. The term ETISOMICIN is an International Non-Proprietary Name. ETISOMICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(O)C(OC2OC(=CCC2N)CN)C(N)CC1N)C1OCC(O)(C(NCC)C1O)C.

UNSPSC 51285905 Etisomicin is a Commodity code nominally identifying a specific antibiotic pharmaceutical product, but the recent state and local opportunities posted under this code do not reflect purchases of etisomicin itself. Instead, the two opportunities on record show state and local health agencies procuring other pharmaceuticals and medical supplies through piggyback contracts and competitive bidding: the Illinois Department of Public Health awarded a three-year pharmaceutical warehouse contract through the MMCAP Infuse consortium to supply Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets totaling $2,999,999.11, and Seminole County, Florida issued a competitive IFB to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually. The code shows activity from state health departments and county health agencies soliciting routine pharmaceutical inventory and emergency medical supplies through established cooperative purchasing vehicles and standard invitation-for-bid processes.

Geographic activity centers on Illinois and Florida, based on the recent record. The Illinois Department of Public Health's MMCAP Infuse piggyback award (posted August 28, 2026, with response deadline September 11, 2026) and Seminole County's naloxone procurement IFB (posted June 30, 2026, with response deadline July 26, 2026) represent the available recent opportunities. Neither opportunity required set-asides or business-enterprise preferences. The code's recent activity is sparse and does not reflect targeted procurement of the etisomicin product itself; vendors evaluating this code should note the mismatch between the nominal commodity classification and the actual pharmaceuticals and supplies being bought under it in current state and local solicitations.